KRAS and colonic neoplasm: The oncogenic KRAS-mediated signaling pathway is required for HIF1α stabilization and activation in colon cancers.38,51 Our findings show that knockdown of RAGE in pancreatic tumor cells inhibits mutant KRAS activation and subsequent HIF1α stabilization and transactivation.